Evaluation of canine‐specific minocycline and doxycycline susceptibility breakpoints for meticillin‐resistant Staphylococcus pseudintermedius isolates from dogs
- 28 July 2015
- journal article
- research article
- Published by Wiley in Veterinary Dermatology
- Vol. 26 (5) , 334-e71
Abstract
Background Using the US Clinical and Laboratory Standards Institute (CLSI) human tetracycline breakpoints to predict minocycline and doxycycline susceptibility of Staphylococcus pseudintermedius (SP) isolates from dogs is not appropriate because they are too high to meet pharmacokinetic/pharmacodynamic data using a standard dose. New breakpoints have been approved for doxycycline and proposed for minocycline. Revised breakpoints are four dilutions lower than tetracycline breakpoints, providing a more conservative standard for classification of isolates. Hypothesis/Objectives The objectives of this study were to measure minimum inhibitory concentrations (MICs) of minocycline and doxycycline of 100 canine meticillin‐resistant SP clinical isolates, compare their susceptibilities to minocycline and doxycycline based on current and revised standards, and document their tetracycline resistance genes. Methods E‐test strips were used to determine MICs. PCR was used to identify tet genes. Results Using the human tetracycline breakpoint of MIC ≤ 4 μg/mL, 76 isolates were susceptible to minocycline and 36 isolates were susceptible to doxycycline. In contrast, using the proposed minocycline breakpoint (MIC ≤ 0.25 μg/mL) and approved doxycycline breakpoint (MIC ≤ 0.125 μg/mL), 31 isolates were susceptible to both minocycline and doxycycline. Thirty‐one isolates carried no tet genes, two had tet(K) and 67 had tet(M). Conclusions and clinical importance Use of the human tetracycline breakpoints misclassified 45 and five of the isolates as susceptible to minocycline and doxycycline, respectively. PCR analysis revealed that 43 and five of the isolates classified as susceptible to minocycline and doxycycline, respectively, possessed the tetracycline resistance gene, tet(M), known to confer resistance to both drugs. These results underscore the importance of utilizing the proposed minocycline and approved doxycycline canine breakpoints in place of human tetracycline breakpoints.Keywords
Funding Information
- American College of Veterinary Dermatology (00035869)
This publication has 22 references indexed in Scilit:
- Doxycycline concentration over time after storage in a compounded veterinary preparationJournal of the American Veterinary Medical Association, 2013
- Evaluation of minocycline susceptibility of methicillin-resistant Staphylococcus pseudintermediusVeterinary Microbiology, 2013
- Meticillin‐resistantStaphylococcus pseudintermedius: clinical challenge and treatment optionsVeterinary Dermatology, 2012
- Selection of antibiotics for meticillin‐resistantStaphylococcus pseudintermedius: time to revisit some old drugs?Veterinary Dermatology, 2012
- Ceftaroline: A Novel Cephalosporin with Activity against Methicillin-resistant Staphylococcus aureusClinical Infectious Diseases, 2011
- Identification of Staphylococcus intermedius Group by MALDI-TOF MSSystematic and Applied Microbiology, 2011
- The Staphylococcus intermedius group of bacterial pathogens: species re‐classification, pathogenesis and the emergence of meticillin resistanceVeterinary Dermatology, 2009
- Staphylococcus pseudintermedius versus Staphylococcus intermediusVeterinary Microbiology, 2009
- Reclassification of Phenotypically Identified Staphylococcus intermedius StrainsJournal of Clinical Microbiology, 2007
- Staphylococcus pseudintermedius sp. nov., a coagulase-positive species from animalsInternational Journal of Systematic and Evolutionary Microbiology, 2005